128 related articles for article (PubMed ID: 38326996)
21. Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma?
Gweon HM; Kim JA; Youk JH; Hong SW; Lim BJ; Yoon SO; Park YM; Son EJ
Diagn Cytopathol; 2016 Feb; 44(2):103-7. PubMed ID: 26681546
[TBL] [Abstract][Full Text] [Related]
22. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.
Proietti A; Borrelli N; Giannini R; Romani R; Di Coscio G; Quilici F; Rago T; Miccoli P; Vitti P; Basolo F
Cancer Cytopathol; 2014 Oct; 122(10):751-9. PubMed ID: 24913568
[TBL] [Abstract][Full Text] [Related]
24. The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
Lee HB; Joung JG; Kim J; Lee KM; Ryu HS; Lee HO; Moon HG; Park WY; Noh DY; Han W
Cancer Cytopathol; 2015 Nov; 123(11):669-77. PubMed ID: 26265110
[TBL] [Abstract][Full Text] [Related]
25. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
[TBL] [Abstract][Full Text] [Related]
26. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules.
Ye W; Hannigan B; Zalles S; Mehrotra M; Barkoh BA; Williams MD; Cabanillas ME; Edeiken-Monroe B; Hu P; Duose D; Wistuba II; Medeiros LJ; Stewart J; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2019 Mar; 127(3):146-160. PubMed ID: 30620446
[TBL] [Abstract][Full Text] [Related]
27. BRAF
Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
[TBL] [Abstract][Full Text] [Related]
28. Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration.
Kouba E; Ford A; Brown CG; Yeh C; Siegal GP; Manne U; Eltoum IE
Am J Clin Pathol; 2018 Jul; 150(2):177-185. PubMed ID: 29868707
[TBL] [Abstract][Full Text] [Related]
29. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
[TBL] [Abstract][Full Text] [Related]
30. Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.
Kim M; Kwon CH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Choi KU; Kim IJ; Park M; Kim BH
Endocrinol Metab (Seoul); 2021 Oct; 36(5):1086-1094. PubMed ID: 34731936
[TBL] [Abstract][Full Text] [Related]
31. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases.
Zarkesh M; Zadeh-Vakili A; Akbarzadeh M; Nozhat Z; Fanaei SA; Hedayati M; Azizi F
Life Sci; 2019 Apr; 223():166-173. PubMed ID: 30890403
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Assessment of BRAF Mutation in Preoperative Thyroid Fine-Needle Aspiration Specimens.
Abi-Raad R; Prasad ML; Zheng J; Hui P; Ustun B; Schofield K; Cai G; Adeniran AJ
Am J Clin Pathol; 2021 Jun; 156(1):100-108. PubMed ID: 33527115
[TBL] [Abstract][Full Text] [Related]
33. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.
Nechifor-Boilă A; Decaussin-Petrucci M; Gazzo S; Paşcanu I; Borda A
Rom J Morphol Embryol; 2012; 53(2):263-7. PubMed ID: 22732794
[TBL] [Abstract][Full Text] [Related]
34. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
Chang H; Lee H; Yoon SO; Kim H; Kim A; Kim BH
Hum Pathol; 2012 Jan; 43(1):89-95. PubMed ID: 21774961
[TBL] [Abstract][Full Text] [Related]
35. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.
Adeniran AJ; Theoharis C; Hui P; Prasad ML; Hammers L; Carling T; Udelsman R; Chhieng DC
Thyroid; 2011 Jul; 21(7):717-23. PubMed ID: 21568726
[TBL] [Abstract][Full Text] [Related]
36. Thyroid Fine Needle Aspiration, the Bethesda System, and the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Association and Prediction for Biopsy.
Galán-García ME; Martínez-Martin MS; Araujo-Ruano EJ; Loro-Ferrer JF; Saavedra-Santana P; Salido-Ruiz E; Cabrera-Galván JJ
Acta Cytol; 2023; 67(4):346-356. PubMed ID: 36592623
[TBL] [Abstract][Full Text] [Related]
37. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
[TBL] [Abstract][Full Text] [Related]
38. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma.
Smith AL; Williams MD; Stewart J; Wang WL; Krishnamurthy S; Cabanillas ME; Roy-Chowdhuri S
Cancer Cytopathol; 2018 Jun; 126(6):406-413. PubMed ID: 29579361
[TBL] [Abstract][Full Text] [Related]
39. The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine-Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment.
Zha X; Miao Z; Huang X; Wang X; Xie R; Jin J; Zou D; Yang P; Huang Y
Front Endocrinol (Lausanne); 2022; 13():822423. PubMed ID: 35197932
[TBL] [Abstract][Full Text] [Related]
40. Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.
Guo HQ; Zhao H; Zhang ZH; Zhu YL; Xiao T; Pan QJ
Dis Markers; 2014; 2014():912182. PubMed ID: 24591770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
